Allianz Asset Management GmbH Makes New Investment in MKS Inc. $MKSI

Key Points

• Allianz Asset Management purchased 34,970 MKS shares valued at approximately $15.6 million, while institutional investors and hedge funds collectively own 99.79% of the company.
• MKS exceeded quarterly expectations, reporting adjusted EPS of $3.30 versus the $2.91 consensus and revenue of $1.25 billion, up 28.3% year over year. The company also maintained a quarterly dividend of $0.25 per share.
• Analyst sentiment remains positive, with the stock carrying a “Moderate Buy” consensus rating and an average price target of $382.86. However, insiders sold 10,757 shares worth about $3.2 million over the past 90 days.

Allianz Asset Management GmbH purchased a new position in shares of MKS Inc. (NASDAQ:MKSI - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 34,970 shares of the scientific and technical instruments company's stock, valued at approximately $15,555,000. Allianz Asset Management GmbH owned approximately 0.05% of MKS at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of MKS by 3.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 267,421 shares of the scientific and technical instruments company's stock worth $21,434,000 after purchasing an additional 9,170 shares during the last quarter. EverSource Wealth Advisors LLC boosted its stake in MKS by 63.4% in the second quarter. EverSource Wealth Advisors LLC now owns 838 shares of the scientific and technical instruments company's stock valued at $83,000 after acquiring an additional 325 shares during the last quarter. First Trust Advisors LP grew its stake in shares of MKS by 3,545.6% during the second quarter. First Trust Advisors LP now owns 141,267 shares of the scientific and technical instruments company's stock worth $14,036,000 after purchasing an additional 137,392 shares during the period. Cerity Partners LLC acquired a new stake in shares of MKS in the 2nd quarter valued at approximately $1,676,000. Finally, AXA S.A. raised its holdings in MKS by 22.8% in the second quarter. AXA S.A. now owns 29,253 shares of the scientific and technical instruments company's stock worth $2,907,000 after purchasing an additional 5,430 shares during the period. 99.79% of the stock is owned by institutional investors and hedge funds.

Insider Activity at MKS

In other MKS news, CEO John Tseng-Chung Lee sold 10,000 shares of MKS stock in a transaction on Friday, August 14th. The shares were sold at an average price of $302.01, for a total value of $3,020,100.00. Following the sale, the chief executive officer directly owned 134,776 shares in the company, valued at approximately $40,703,699.76. The trade was a 6.91% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Elizabeth Mora sold 300 shares of the business's stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $250.96, for a total transaction of $75,288.00. Following the sale, the director directly owned 18,845 shares in the company, valued at $4,729,341.20. This trade represents a 1.57% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 10,757 shares of company stock valued at $3,227,146. Corporate insiders own 0.57% of the company's stock.

MKS Stock Up 2.0%

NASDAQ:MKSI opened at $265.50 on Wednesday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.72 and a current ratio of 1.14. The company has a market cap of $17.95 billion, a PE ratio of 42.34, a PEG ratio of 0.55 and a beta of 1.98. MKS Inc. has a 52-week low of $107.02 and a 52-week high of $447.62. The stock has a 50-day simple moving average of $308.96 and a 200 day simple moving average of $295.81.

MKS (NASDAQ:MKSI - Get Free Report) last released its earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $3.30 EPS for the quarter, beating the consensus estimate of $2.91 by $0.39. The firm had revenue of $1.25 billion for the quarter, compared to analysts' expectations of $1.20 billion. MKS had a return on equity of 24.72% and a net margin of 10.15%.The business's quarterly revenue was up 28.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.77 EPS. MKS has set its Q3 2026 guidance at 3.270-3.890 EPS. On average, sell-side analysts expect that MKS Inc. will post 13.07 EPS for the current fiscal year.

MKS Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 3rd. Investors of record on Tuesday, August 25th were given a $0.25 dividend. The ex-dividend date of this dividend was Tuesday, August 25th. This represents a $1.00 dividend on an annualized basis and a yield of 0.4%. MKS's dividend payout ratio (DPR) is 15.95%.

Analyst Ratings Changes

A number of research firms have recently commented on MKSI. Morgan Stanley raised their price target on MKS from $374.00 to $442.00 and gave the stock an "overweight" rating in a research report on Monday, July 6th. KeyCorp boosted their price objective on MKS from $360.00 to $475.00 and gave the company an "overweight" rating in a research report on Monday, June 29th. Wall Street Zen raised MKS from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 8th. Citigroup raised their target price on shares of MKS from $425.00 to $430.00 and gave the stock a "buy" rating in a report on Friday, August 7th. Finally, BMO Capital Markets started coverage on shares of MKS in a research note on Tuesday, June 30th. They issued an "outperform" rating and a $453.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $382.86.

About MKS

MKS Instruments, Inc NASDAQ: MKSI designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company's core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company's product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.

Want to see what other hedge funds are holding MKSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MKS Inc. (NASDAQ:MKSI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.